Cite

HARVARD Citation

    Clerico, M. et al. (2021). COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment. HemaSphere. 5 (7), pp. e592-. [Online]. 
  
Back to record